Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health, through the National Heart, Lung, and Blood Institute, is seeking contractor support for the Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD) project. The primary objective is to build and maintain a cohort of individuals with sickle cell disease who have undergone either gene therapy or hematopoietic cell transplantation. The contractor will be responsible for sustaining long-term follow-up activities for enrolled participants to help determine the safety, durability, and effectiveness of these treatments. This initiative aims to provide rigorous comparisons between patients receiving these transformative therapies and untreated individuals with sickle cell disease. The project is categorized under NAICS code 541715 and is managed by the National Institutes of Health, with program coordination handled by Lisbeth Welniak and contracting oversight provided by Elizabeth Bulger.

General Info

NIH seeks contractor to maintain a long-term sickle cell disease treatment follow-up cohort.

Agency

National Institutes of Health → National Institutes Of HealthView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyNational Institutes of Health → National Institutes Of Health
Contacts2 people available
OfficeN/A
Organization / Agency
National Institutes of Health → National Institutes Of Health
View Agency Profile
Office AddressN/A
Contacts
Lisbeth Welniak
Elizabeth BulgerContracting Officer

Full Description

Show more
The National Heart, Lung, and Blood Institute (NHLBI) requires contractor support to continue building a cohort of individuals with sickle cell disease (SCD) who have received gene therapy (GT) or hematopoietic cell transplantation (HCT) and to sustain long-term follow-up (LTFU) activities for enrolled participants. While both therapies are available, it has not been established which is safer, more durable, or most effective, nor have rigorous comparisons to untreated persons with SCD who have chosen not to undergo one of these treatments undertaken.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
IDIQ University of Nebraska National Strategic Research Institute NSRIThe National Nuclear Security Administration under the Department of Energy has forecasted an Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract opportunity through the University of Nebraska’s National Strategic Research Institute. This acquisition aims to support mission-critical research and technical services related to national security, with a focus on scientific and engineering capabilities aligned with the NAICS code 541715 for research and development in the physical, engineering, and life sciences. The contract will provide a flexible vehicle for awarding multiple task orders over its lifetime, allowing the government to procure a wide range of services as needs arise without requiring separate competitions for each task. There is no specified set-aside type, and performance locations are not defined, indicating potential nationwide or multi-site execution depending on task requirements. The point of contact for this forecast is Chelsea Murphy, the Small Business Program Manager, who can be reached via email for inquiries related to small business participation and procurement opportunities. While the solicitation number and detailed scope are not yet available, the posting date indicates this is a pre-solicitation notice, serving to inform industry and potential offerors of an upcoming opportunity. Interested parties should monitor official channels for the formal solicitation, which will include detailed requirements, evaluation criteria, and submission instructions. The absence of a specific place of performance suggests that contractors may be expected to support operations at various federal facilities or partner locations as directed by task orders issued under this IDIQ.
National Nuclear Security Administration

POSTED

about 6 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
LIPTM00183, INIS IPT, IWRP BRPP BYOBThe contract opportunity titled LIPTM00183, INIS IPT, IWRP BRPP BYOB, issued by Naval Information Warfare Systems under NIWC Atlantic, focuses on Bring Your Own Bits within the Electromagnetic Spectrum technical domain. This pre-solicitation collaboration aims to engage industry partners early in the acquisition process to refine requirements and encourage innovative solutions tailored to operational needs in electronic warfare, signal intelligence, and spectrum dominance. The place of performance is designated as Charleston, and the NAICS code 541715 identifies the work as research and development in physical, engineering, and life sciences, indicating a strong emphasis on advanced technical innovation. Giancarlo Dumenigo, the Contracting Officer, serves as the primary point of contact for inquiries and collaboration efforts, and interested parties are encouraged to engage prior to formal solicitation to align capabilities with mission goals. While no solicitation number has been issued yet and the type of set-aside is not specified, the forecasted nature of this posting signals an upcoming competitive procurement process likely open to small businesses and other eligible entities. Participants should prepare technical proposals that demonstrate agility, interoperability, and cutting-edge advancements in electromagnetic spectrum systems, leveraging proprietary or commercially available technologies to fill critical capability gaps for the Navy.
Niwc Atlantic

POSTED

about 6 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
UAVIO Code 756 Requirement (C)The contract seeks engineering and technician support for Unmanned Aerial Vehicle Information Operations under the UAVIO Code 756 Requirement, focused on enhancing information operations capabilities through unmanned systems. The effort is managed by Naval Information Warfare Systems Pacific, with performance centered in San Diego, and is classified under NAICS code 541715, indicating it involves research and development in the field of computer systems design. The solicitation is currently listed as a forecast, meaning it is a pre-solicitation notice to gauge industry interest and prepare for future procurement, with no formal solicitation number issued yet. All work is expected to support Navy-specific UAVIO missions requiring specialized technical expertise in software, data integration, and operational systems. David Roden serves as the primary point of contact for this requirement, with Joshua J. Joiner listed as the secondary point of contact, both reachable through official Navy email addresses. The contract is not currently designated with a specific set-aside classification, suggesting it may be open to all eligible small and large businesses without restriction. The timeline targets a posting date of August 2026, indicating the anticipated issuance of a formal solicitation around that timeframe. Interested vendors should monitor the official AMS portal via the provided UI link for future updates and documentation leading up to the actual request for proposals.
Niwc Pacific

POSTED

about 6 hours ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Federal
Hazardous Weather Detection and Display Capability (HWDDC) systems SBIR Phase IIIThe contract is for the Hazardous Weather Detection and Display Capability (HWDDC) systems under a Small Business Innovation Research (SBIR) Phase III effort, aimed at advancing weather sensing and display technologies for naval operational use. It is managed by Niwc Pacific, part of the Naval Information Warfare Systems organization, with performance expected in San Diego. The NAICS code 541715 indicates the work involves scientific research and development services, specifically focused on enhancing situational awareness through improved hazardous weather detection systems. This effort is forecasted to be released on August 10, 2026, and is not currently open for bids but signals the Navy’s intent to pursue advanced weather capabilities for maritime environments. The primary point of contact is Eric Pomroy, the Contracting Officer, reachable via email, with Jon Ventura serving as the secondary point of contact for additional inquiries. No solicitation number or set-aside designation is listed, suggesting the opportunity is still in the planning phase and may not yet have defined procurement parameters such as size standards or small business preferences. The contract is anticipated to support Navy missions by integrating robust, real-time weather data systems into tactical platforms, improving safety and decision-making during operations exposed to severe atmospheric conditions. Further details regarding scope, funding, or deadlines will be released in a formal solicitation following the forecast date.
Niwc Pacific

POSTED

about 6 hours ago

DEADLINE

N/A
View Details

More opportunities from National Institutes of Health → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Federal
National NeuroHIV Tissue Consortium (NNTC) - Clinical Sites
Solicitation # 75N98026R00139
The National Institute of Mental Health plans to modify two existing contracts with the University of California, San Diego and Washington University to increase funding for Task 2 of the National NeuroHIV Tissue Consortium, which supports clinical research on HIV-related neurocognitive and mental health outcomes. The modification to UCSD’s contract will raise its value by $269,941 to $13,774,419, extending performance through August 22, 2027, while WASHU’s contract will increase by $543,301.63 to $8,322,165.63 through September 22, 2027. These adjustments are necessary to sustain critical participant recruitment, clinical assessments, and longitudinal follow-up essential for advancing HIV cure research, particularly through viral reservoir assays and other cure-relevant measures that leverage existing, deeply characterized cohorts. The work also includes the collection, storage, and distribution of central and peripheral nervous system tissues, cerebrospinal fluid, and associated clinical data to a national research community, aligning with the NIMH’s mission to understand how immune dysregulation and psychosocial stress impact brain health. The contracts are sole-source actions authorized under 41 U.S.C. 3304(a)(1) and the Revolutionary FAR Overhaul, as no other entities possess the established infrastructure, participant pools, and neuropsychiatric expertise required to continue this work without disruption. Classified under NAICS code 541715 with a 1,000-employee small business size standard, the effort supports a national resource established in 1998 that provides high-quality biospecimens and clinical data from both HIV-positive and HIV-negative donors. The modification ensures continuity in advancing research on HIV-associated CNS complications, aging with long-term HIV and antiretroviral therapy, and mechanisms underlying neurocognitive decline. While no competitive solicitation will be issued, interested parties may submit capability statements or objections by August 22, 2026, to the Contracting Officer at NIH, with all responses required to include active SAM registration, a Unique Entity Identifier, and Taxpayer Identification Number. The government retains full discretion to proceed non-competitively regardless of received feedback.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

in 6 days
View Details
NAICS: 811210
Federal
Preventative Maintenance Service Contract for the Scan Module LSM 880 Microscope
Solicitation # 75N98026Q00966
The National Institutes of Health intends to award a sole-source preventative maintenance service contract to Carl Zeiss Microscopy for the Scan Module LSM 880 Microscope, serial number 2802000272, an existing government-owned instrument originally manufactured by the same vendor. The contract requires that all maintenance be performed by OEM-certified factory-trained technicians using only OEM-authorized parts, ensuring the highest level of technical compatibility and performance integrity. Due to the proprietary nature of the equipment and the specialized expertise required, Carl Zeiss Microscopy is the only vendor capable of meeting these specifications, justifying the sole-source procurement approach. The solicitation, identified by number 75N98026Q00966, was posted on August 6, 2026, with responses due by August 21, 2026, and the service contract is expected to be awarded around September 15, 2026. The contract falls under NAICS code 811210 for scientific and technical services and will be managed by the National Institutes of Health under the Department of Health and Human Services. Performance is scheduled to occur in Baltimore, Maryland, while the contracting office is located in Bethesda, Maryland. Polina Klimenkova is the point of contact for inquiries, and all necessary details are available through the provided SAM.gov link.
Electronic and Precision Equipment Repair and Maintenance

POSTED

10 days ago

DEADLINE

in 5 days
View Details
NAICS: 541715
SBIR / STTR
Development of devices, diagnostic technologies, or digital health tools for treatment, detection, and diagnosis of Pediatric Cancers and/or Rare Cancers.
Solicitation # 2
In the United States, cancer remains the leading cause of death from disease among children aged 1 to 14, with approximately 9,550 cases expected to be diagnosed in 2025 among those under 15. Rare cancers, defined by the FDA as affecting fewer than 200,000 individuals nationwide, are the top cause of cancer-related deaths overall, yet they suffer from drastically underfunded and slow-moving research pipelines due to small patient populations and complex development pathways. This funding opportunity targets innovative, high-risk, and disruptive technologies aimed at preventing, detecting, diagnosing, or treating pediatric and rare cancers, prioritizing bold ideas with strong scientific merit over incremental advances or those relying on preliminary data. Applicants must clearly articulate the clinical unmet need, specify the cancer types addressed using authoritative prevalence data, and design experiments to generate foundational proof-of-concept evidence that de-risks their approach. The NCI SBIR Innovative Concept Award supports small businesses with fewer than 500 employees in developing transformative devices, diagnostic tools, or digital health solutions tailored to these underserved populations. While preliminary data is not required, proposals must be grounded in sound scientific reasoning from published literature or the applicant’s own research. Activities may include early prototype development, phantom and in vivo validation, biomarker optimization, analytic validation of assays, and testing in deidentified clinical samples, depending on the technology type. Beyond technical validation, applicants are expected to explore commercial viability, including business modeling and commercialization strategy, with additional support provided through entrepreneurship training. The goal is to generate actionable data that moves ideas closer to market readiness, culminating in a formal report to the NCI summarizing results and demonstrating technical feasibility. The solicitation is open to small businesses through a total small business set-aside, with proposals due by September 21, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
SBIR / STTR
Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers.
Solicitation # 1
Each year, approximately 9,550 children under 15 in the United States are diagnosed with cancer, making it the leading cause of death from disease in children ages 1 to 14 after infancy, while rare cancers collectively represent the top cause of cancer-related deaths nationwide. Defined by the FDA Orphan Drug Act as malignancies affecting fewer than 200,000 individuals in the U.S., rare cancers and pediatric cancers face significant developmental challenges due to small patient populations and limited clinical data, resulting in slower progress in treatment innovation compared to more common cancers. This initiative seeks bold, high-risk, and transformative technologies—therapies, diagnostics, devices, or preventive strategies—that address critical unmet needs in these underserved areas, with a strong emphasis on disruptive ideas grounded in sound scientific principles rather than incremental improvements. Preliminary data is not required, but proposals must clearly articulate the clinical problem, specify the targeted cancer type supported by authoritative prevalence estimates from sources like SEER, and outline a plausible pathway to meaningful improvement in survival or care. The funding program is designed to support early-stage proof-of-concept research that de-risks innovation, enabling applicants to generate key technical validation data within the award period. Offerors are expected to propose experiments tailored to their technology, such as target validation, lead optimization, in vivo efficacy testing, or preliminary pharmacokinetic studies, and deliver a final report documenting outcomes. In addition to financial support, recipients will receive business and commercialization coaching to refine their business models and explore viable development pathways, with the ultimate goal of translating novel concepts into viable solutions for pediatric and rare cancer patients. This solicitation is exclusively available to small businesses with fewer than 500 employees under a Total Small Business Set-Aside and is open for applications through September 21, 2026.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

in about 1 month
View Details
NAICS: 541519
Federal
Justification for Cancellation of Solicitation No. CS-119444-O
Solicitation # CS-119444-O
The National Institutes of Health, under the Department of Health and Human Services, canceled Solicitation No. CS-119444-O issued through the NITAAC CIO-SP3 GWAC vehicle on June 25, 2026, due to strategic misalignment with the agency’s evolving enterprise IT centralization initiative and updated cybersecurity mandates. The original solicitation sought comprehensive IT services including application modernization, cloud and SharePoint migration, cybersecurity operations, network management, infrastructure support, software development, and PMO oversight, all intended to advance NIH’s digital transformation goals. However, the scope was deemed outdated in light of new federal directives such as Executive Order 14028, OMB M-22-09 on Zero Trust Architecture, and Executive Order 14240, which necessitate a broader, more integrated approach under revised governance frameworks. The cancellation occurred prior to any offeror submissions, evaluations, or award, meaning no pricing, contract value, or performance timelines were established, and no special contract requirements, clauses, or evaluation criteria were finalized or enforced. The place of performance remains Bethesda, Maryland, with the Office of Acquisition and Logistics Management maintaining oversight through Contracting Officer Justin M. Borden. The solicitation was not set aside for any socioeconomic category and was open to all businesses. All intended deliverables, standards, and compliance obligations tied to the original Performance Work Statement are no longer viable, requiring a re-compete under a consolidated IT services vehicle aligned with current federal IT and cybersecurity policies.
Other Computer Related Services

POSTED

about 2 months ago

DEADLINE

N/A
View Details